US Stock MarketDetailed Quotes

RIGL Rigel Pharmaceuticals

Watchlist
  • 25.040
  • +0.730+3.00%
Close Nov 21 16:00 ET
  • 25.438
  • +0.398+1.59%
Post 20:02 ET
441.08MMarket Cap92.74P/E (TTM)

Rigel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rigel Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
41.93M
55.31M
+13.37M
Beat Est.
+49.05%
+96.58%
+31.89%
EPS
0.07
0.70
+0.63
Beat Est.
+123.34%
+312.12%
+900.00%
Analyst Rating
Buy

Nov 21, 2024

Rigel Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 43.493M--
--2024/Q4-- / 47.421M--
Nov 7, 20242024/Q355.307M / 41.934M--
Aug 6, 20242024/Q236.841M / 33.704M--
May 7, 20242024/Q129.534M / 31.472M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 43.493M--
--2024/Q4-- / 47.421M--
Nov 7, 20242024/Q355.307M / 41.934M--
Aug 6, 20242024/Q236.841M / 33.704M--
May 7, 20242024/Q129.534M / 31.472M--

Unlock Free Earnings Estimates

Rigel Pharmaceuticals Earnings Reports

  • Rigel Pharmaceuticals | 8-K: Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 8 05:29

  • Rigel Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 8 05:14

  • Rigel Pharmaceuticals | 8-K: Press Release, dated August 6, 2024, titled “Rigel Reports Second Quarter 2024 Financial Results and Provides Business Update.”

    Aug 7 04:15

  • Rigel Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 7 04:09

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 21, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data